Investors Research Corp’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$27.6K Hold
124
– – ﹤0.01% 441
2026
Q2
$29.5K Buy
+124
New +$25.8K 0.01% 439
2022
Q3
– Sell
-1,096
Closed -$57K – 1093
2022
Q2
$57K Hold
1,096
– – 0.02% 485
2022
Q1
$62K Hold
1,096
– – 0.02% 487
2021
Q4
$56K Hold
1,096
– – 0.02% 505
2021
Q3
$54K Hold
1,096
– – 0.02% 508
2021
Q2
$63K Hold
1,096
– – 0.02% 478
2021
Q1
$67K Hold
1,096
– – 0.03% 461
2020
Q4
$59K Hold
1,096
– – 0.02% 505
2020
Q3
$51K Hold
1,096
– – 0.02% 502
2020
Q2
$57K Hold
1,096
– – 0.03% 459
2020
Q1
$53K Hold
1,096
– – 0.03% 432
2019
Q4
$55K Hold
1,096
– – 0.03% 505
2019
Q3
$52K Hold
1,096
– – 0.03% 504
2019
Q2
$52K Hold
1,096
– – 0.03% 497
2019
Q1
$53K Buy
+1,096
New +$54.9K 0.03% 498

Other funds holding CAH

Investors Research Corp's CAH Position: Q3 2026 in Review

Investors Research Corp held its Cardinal Health (CAH) position steady in Q3 2026 at 124 shares worth $27.6K. The position accounts for ﹤0.01% of the portfolio, ranked #441.

Investors Research Corp first reported a position in CAH in Q1 2019 and has held it in 16 quarters since. The position peaked at $67K in Q1 2021. 52 funds tracked by Wall St. Rank hold CAH as of Q3 2026.

  • Investors Research Corp held 124 shares of Cardinal Health worth $27.6K as of Q3 2026.
  • Investors Research Corp left its Cardinal Health share count unchanged in Q3 2026.
  • Cardinal Health made up ﹤0.01% of Investors Research Corp's portfolio in Q3 2026, its #441 holding.
  • Investors Research Corp first reported a position in Cardinal Health in Q1 2019 and has held it in 16 quarters since.
  • Investors Research Corp's Cardinal Health position peaked at $67K in Q1 2021.
  • 52 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2026.

Based on Investors Research Corp's 13F filing for Q3 2026, filed 7 Oct 2026.